Axa S.A. Buys Shares of 54,027 Phibro Animal Health Co. (NASDAQ:PAHC)

Axa S.A. purchased a new stake in Phibro Animal Health Co. (NASDAQ:PAHC) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 54,027 shares of the company’s stock, valued at approximately $906,000. Axa S.A. owned approximately 0.13% of Phibro Animal Health at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of PAHC. Sofinnova Investments Inc. purchased a new stake in Phibro Animal Health in the 2nd quarter valued at approximately $3,975,000. American Century Companies Inc. grew its position in Phibro Animal Health by 119.6% during the second quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after acquiring an additional 189,068 shares during the period. Acadian Asset Management LLC increased its stake in Phibro Animal Health by 32.8% during the first quarter. Acadian Asset Management LLC now owns 675,207 shares of the company’s stock worth $8,726,000 after acquiring an additional 166,776 shares during the last quarter. Wellington Management Group LLP increased its stake in Phibro Animal Health by 165.9% during the fourth quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock worth $1,908,000 after acquiring an additional 102,793 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Phibro Animal Health by 5.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock worth $13,005,000 after purchasing an additional 42,086 shares during the period. 99.34% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Phibro Animal Health

In related news, Director E Thomas Corcoran purchased 5,000 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The stock was acquired at an average price of $20.02 per share, with a total value of $100,100.00. Following the completion of the transaction, the director now owns 25,000 shares of the company’s stock, valued at $500,500. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 50.06% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on PAHC. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price for the company. Bank of America increased their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $15.00.

Phibro Animal Health Stock Down 2.0 %

Shares of NASDAQ:PAHC opened at $22.08 on Wednesday. The company has a 50 day moving average of $19.82 and a two-hundred day moving average of $17.33. Phibro Animal Health Co. has a 52-week low of $9.40 and a 52-week high of $22.84. The company has a quick ratio of 1.64, a current ratio of 2.94 and a debt-to-equity ratio of 1.79. The company has a market capitalization of $894.31 million, a price-to-earnings ratio of 69.00, a price-to-earnings-growth ratio of 1.77 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.08%. The business had revenue of $273.16 million during the quarter, compared to analyst estimates of $262.44 million. As a group, analysts forecast that Phibro Animal Health Co. will post 1.44 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.17%. The ex-dividend date was Wednesday, September 4th. Phibro Animal Health’s dividend payout ratio (DPR) is 150.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.